The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses

PLoS One. 2015 May 1;10(5):e0123163. doi: 10.1371/journal.pone.0123163. eCollection 2015.

Abstract

Background: Chronic rhinosinusitis (CRS) is characterized by epithelial activation and chronic T-cell infiltration in sinonasal mucosa and nasal polyps. IL-33 is a new cytokine of the IL-1 cytokine family that has a pro-inflammatory and Th2 type cytokine induction property. The role of IL-33 in the pathomechanisms of CRS and its interaction with other T cell subsets remain to be fully understood.

Methods: The main trigger for IL-33 mRNA expression in primary human sinonasal epithelial cells was determined in multiple cytokine and T-cell stimulated cultures. The effects of IL-33 on naïve, Th0 and memory T-cells was studied by PCR, ELISA and flow cytometry. Biopsies from sinus tissue were analyzed by PCR and immunofluorescence for the presence of different cytokines and receptors with a special focus on IL-33.

Results: IL-33 was mainly induced by IFN-γ in primary sinonasal epithelial cells, and induced a typical CRSwNP Th2 favoring cytokine profile upon co-culture with T-helper cell subsets. IL-33 and its receptor ST2 were highly expressed in the inflamed epithelial tissue of CRS patients. While IL-33 was significantly up-regulated in the epithelium for CRSsNP, its receptor was higher expressed in sinus tissue from CRSwNP.

Conclusions: The present study delineates the influence of IL-33 in upper airway epithelium and a potential role of IL-33 in chronic inflammation of CRSwNP by enhancing Th2 type cytokine production, which could both contribute to a further increase of an established Th2 profile in CRSwNP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / drug effects
  • Chronic Disease
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Humans
  • Immunologic Memory / drug effects
  • Inflammation Mediators / metabolism
  • Interferon-gamma / pharmacology
  • Interleukin-33 / metabolism*
  • Models, Biological
  • Nasal Mucosa / drug effects
  • Nasal Mucosa / immunology*
  • Nasal Mucosa / pathology
  • Paranasal Sinuses / pathology*
  • Rhinitis / immunology
  • Rhinitis / pathology
  • Sinusitis / immunology
  • Sinusitis / pathology
  • T-Lymphocytes, Helper-Inducer / drug effects
  • T-Lymphocytes, Helper-Inducer / immunology*
  • Up-Regulation / drug effects

Substances

  • Inflammation Mediators
  • Interleukin-33
  • Interferon-gamma

Grants and funding

This work was supported by grants from: Swiss National Science Foundation Grants No. 320030_140772, 320030_132899; Müller-Gierok Foundation, Bern; funds from the Oesterreichische Nationalbank (Anniversary Fund, project number 13846ONB); Christine Kühne-Center for Allergy Research and Education, Davos; and Austrian Science Fund Project, grant numbers F4615-B19, F4605-B19. Tomasz M. Basinski was the recipient of European Respiratory Society Fellowship (Number 312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.